The paradox of cholesterol and stroke
- 1 December 2007
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 370 (9602) , 1803-1804
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deathsThe Lancet, 2007
- Long-Term Follow-up of the West of Scotland Coronary Prevention StudyNew England Journal of Medicine, 2007
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Statins in Stroke Prevention and Carotid AtherosclerosisStroke, 2004
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Stroke prevention, blood cholesterol, and statinsThe Lancet Neurology, 2004
- Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid StenosisNew England Journal of Medicine, 1997
- Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohortsThe Lancet, 1995
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989